Press releasePRNewswire
Clearpoint Neuro
CLPT · NASDAQ
$9.45+$0.28 (+3.05%)TodayMarket closed ·
Prev close $9.17
Latest news
- Press releaseACCESS Newswire
ClearPoint Neuro to Announce Third Quarter 2026 Results October 28, 2026
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ClearPoint Neuro, Inc. - CLPT
- Press releaseBusiness Wire
CLPT Investors with $100,000 in Losses Have Opportunity to Join ClearPoint Neuro, Inc. Fraud Investigation with SBS Law
- Press releaseGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ClearPoint Neuro, Inc. - CLPT
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- NewsAvi Kapoor
Crude Oil Down Over 5%; McDonald's Earnings Top Views
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- NewsAvi Kapoor
Powell Industries Posts Downbeat Q3 Results, Joins Clearpoint Neuro, Ichor Holdings And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
- NewsAvi Kapoor
Why Palantir Shares Are Trading Higher By 16%; Here Are 20 Stocks Moving Premarket
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- Press releaseACCESS Newswire
ClearPoint Neuro Reports Second Quarter 2026 Results
- Press releaseACCESS Newswire
ClearPoint Neuro Congratulates Partner Aspen Neuroscience on FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Sasineprocel
- Press releaseACCESS Newswire
ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026
- Press releaseGlobe Newswire
Biotech's New Frontier: Companies Breaking Through Medicine's Toughest Barriers
- NewsAvi Kapoor
Jabil Posts Upbeat Q3 Results, Joins Uniqure, Braiin And Other Big Stocks Moving Higher On Wednesday
- Press releaseACCESS Newswire
ClearPoint Neuro Enters into 10-year Focused Ultrasound Development Partnership with Sungkyunkwan University, South Korea, Further Expanding Our Drug Delivery Ecosystem and Global Footprint
- News
ClearPoint Neuro Q1 2026 Earnings Call Transcript
- Press releaseACCESS Newswire
ClearPoint Neuro Reports First Quarter 2026 Results
- Press releaseACCESS Newswire
ClearPoint Neuro Announces CE Marking of Velocity Alpha MR High Speed Surgical Drill System, Further Expanding Drug Delivery Ecosystem and Global Footprint
- News
Earnings Scheduled For May 13, 2026
- News
'Trump Approves Plan To Fire FDA Commissioner Marty Makary, Sources Say' - CBS
- Press releaseACCESS Newswire
ClearPoint Neuro to Announce First Quarter 2026 Results May 13, 2026
- NewsAvi Kapoor
Crude Oil Moves Higher; Jabil Shares Slide After Q2 Results
- News
12 Health Care Stocks Moving In Monday's Intraday Session
- NewsVandana Singh
ClearPoint Neuro Gets EU Green Light For Updated Brain Surgery Software
- Press releaseACCESS Newswire
ClearPoint Neuro Reports Third Quarter 2025 Results
- News
12 Health Care Stocks Moving In Monday's Intraday Session
- NewsAvi Kapoor
Kimberly-Clark, Vertex And Other Big Stocks Moving Lower In Monday's Pre-Market Session
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- NewsAvi Kapoor
uniQure, Hertz Global, Eli Lilly And Other Big Stocks Moving Higher On Thursday
- NewsAvi Kapoor
Autoliv Posts Strong Sales, Joins United States Cellular, Netflix, Intuitive Surgical And Other Big Stocks Moving Higher On Friday
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.